Michele is the inventor of Pertinax technology and a founder of the company. She is also a Reader in biomaterials at the University of Bristol. Michele is highly respected in the field of biomaterials research and has over 50 peer-reviewed publications to her name.
Stuart Gibson is an experienced CFO who since 2001 has focused on early stage biotech and technology companies. During his career he has been involved in a significant number of corporate finance and M&A transactions, an IPO and a wide range of international commercial deals.
Paul is an experienced international business development manager with a track record of delivering year-on-year revenue and margin growth through direct and indirect sales channels, particularly in wound care. He joined Pertinax in December 2017 to advance the company's commercial discussions.
For further information, please contact:
Pertinax Pharma Limited
Future Space , UWE North Gate
Bristol BS34 8RB, United Kingdom
We are not currently recruiting, but when we are, information will appear here.